2025 International Congress Archives

Radiographic Resolution without Clinical Improvement in Anti-Ri Rhombencephalitis

P. Atit, A. Kolli, S. Aghili-Mehrizi, K. Wuthrich, A. Karimi (Tampa, USA)
Random-Order Crossover Trial Assessing the Safety, Feasibility and Exploratory Efficacy of Two Mediterranean-Ketogenic Nutritional Interventions in Parkinson’s Disease

K. Tosefsky, J. Lam, Y. Wang, A. Kuan, S. Appel-Cresswell (Vancouver, Canada)
Randomized Trial comparing Directional DBS with Ring-mode DBS in PD

V. Sisodia, TR. Ten Brinke, H. Jergas, VJJ. Odekerken, D. Verbaan, JM. Dijk, M. Bot, M. Beudel, P. Munckhof, MT. Barbe, PR. Schuurman, RMA. de Bie (Amsterdam, Netherlands)
Randomness and bursting of pallidal spiking activity correlates with DBS outcome in Parkinson’s disease and dystonia

A. Sedov, P. Pavlovsky, V. Filyushkina, I. Dzhalagoniya, U. Semenova, S. Usova, A. Gamaleya, A. Tomskiy (Moscow, Russian Federation)
Rapid Neurologic Decline after Subthalamic Nucleus Deep Brain Stimulation in Leucine-Rich Repeat Kinase 2 Parkinson’s disease (LRRK2-PD)

T. Haddad, M. Rochman, TW. Liang (Phialdelphia, USA)
Rapid Onset Progressive Dystonia with Parkinsonism

D. Nguyen, R. Parihar (Bronx, USA)
Rare DYT23 Dystonia, First Diagnosed Case in Ukraine

Y. Trufanov (Kyiv, Ukraine)
Rare Phenomenology with Nicotinic Ganglionic Acetylcholine Receptor Antibodies

V. Melnic, J. Frey (Morgantown, USA)
Rare Variant Analysis of Sphingolipid-related Genes in Large Chinese Parkinson’ s Disease Cohorts

JB. Liu, YW. Zhao, XM. Guo, Q. Yin, R. Gao, BS. Tang, JF. Guo (Changsha, China)
Rare Variants in RAB GTPases in Parkinson’s Disease

C. Gabbert, AJ. Stoessl, AH. Tan, L. Eade, E. Zhunusova, J. Follett, S. Schaake, BS. Malek, C. Shambetova, K. Andersh, YW. Tay, A. Ahmad-Annuar, Z. Gan-Or, M. Ghamgosar Shahkhali, TS. Toh, GP2. Genetics Program, C. Klein, SY. Lim, D. Alessi, M. Farrer, J. Trinh (Lübeck, Germany)
Rare Variants, Copy Number Variations, and Heritability Estimates in a Pilot Cohort of Egyptians with Parkinson’s Disease

M. Yousef, A. El-Hosseiny, A. Nagano, A. Atputhavadivel, E. Khedr, M. William, A. Shalash, G. Fawy, S. El-Shafie, S. El-Jaafary, M. Koraym, Y. Salah, S. Elfarrash, Y. Elsaid, A. Gabr, N. Shebl, L. Aly, N. Abdelwahhab, T. Belal, N. Elsayed, M. El-Gamal, S. Elgamal, S. Ragab, J. Mekky, M. Salama, M. Rizig (Cairo, Egypt)
Real world application of alpha-synuclein skin biopsy in the diagnosis of synucleinopathies at a tertiary care center

C. Yu, C. Cooper (Nashville, USA)
Real-life experience with continuous subcutaneous foslevodopa/foscarbidopa infusion in advanced stage of Parkinson’s disease at Villa Margherita

G. Nordera, N. Bonetto, F. Perini (Vicenza, Italy)
Real-World Adverse Event Profile in Children and Adolescents With Tourette Syndrome Treated With Dopamine D2 Receptor Antagonists (D2RAs) Compared With Non-D2RAs

K. Tomczak, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, D. Isaacs (Bethesda, USA)
Real-World Clinical and Safety Outcomes from a Prospective, Multicenter Deep Brain Stimulation Registry of Essential Tremor Patients

G. Deuschl, P. Schuurman, G. Loret, N. Kovacs, M. Barbe, M. Blazquez Estrada, F. Clement, S. Jauma Classen, J. Lee, J. Volkmann, D. Pedrosa, A. Oliviera, S. Paschen, L. Chen, R. Shivacharan, E. Goldberg (Kiel, Germany)
Real-World Effectiveness of the 4-Week Patient Deutetrabenazine-Titration Kit for Tardive Dyskinesia Across Races: START Study Post Hoc Analysis

A. Cutler, G. Alva, M. Konings, S. Finkbeiner, K. Anderson (Lakewood Ranch, USA)
Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders

S. Manohar, J. Jacobe, R. Berger, J. Jankovic, M. Hull (Houston, USA)
Real-World USA Outcomes in Patients Implanted with DBS Systems Capable of Directionality and Multiple Independent Current Control

M. Okun, K. Foote, T. Zesiewicz, Y. Bezchlibnyk, A. Papanastassiou, O. Vaou, J. Carlson, J. Aldred, V. Krishna, B. Dalm, J. Durphy, J. Pilitsis, L. Verhagen Metman, S. Sani, D. Kern, S. Ojemann, R. Ramdhani, D. Weintraub, B. Sundaram, A. Siadati, D. Martinez, C. Zhao, M. Siddiqui, S. Tatter, L. Chen, R. Shivacharan, E. Goldberg (Gainesville, USA)
Redefining the Finger-tapping Test in Parkinsonian Patients: Finger to Crease Instead of Finger-to-tip

F. Akhoundi, Y. Bordelon, J. Leverenz, P. Oikonomou, I. Litvan (San Diego, USA)
Reduced Falls With ND0612: Supportive Analyses From the BouNDless Phase 3 Study

S. Isaacson, F. Stocchi, A. Ellenbogen, N. Lopes, N. Sasson, J. Pereira, O. Rascol (Boca Raton, USA)
Reduced plasma levels of small HDL subfractions in advanced Parkinson’s disease

CM. Chen, KH. Chang, ML. Cheng (Taoyuan, Taiwan)
Refining a Claims-Based Severity Rating Scale for Parkinson’s Disease Using Machine Learning

E. Krause, L. Kovalchick, A. Medhus, J. Theo, C. Truong, S. Park, X. Zhang, X. Jiang, T. Krause (Austin, USA)
Refining the International Parkinson and Movement Disorder Society Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS): Cognitive Interview Results from an International Study

M. Tosin, T. Mestre, G. Stebbins, G. Mangone, S. Videmsky, S. Ali, D. Aarsland, J. Goldman, T. Khoo, S. Lewis, P. Martinez-Martin, O. Ojo, J. Pagonabarraga, A. Schrag, D. Weintraub, C. Goetz (Chicago, USA)
Refractory Orthostatic Hypotension, Anterocollis Predominant Cervical Dystonia and Parkinsonism Associated with a Previously Undiscovered SYT14 Gene Mutation

W. Gan, O. Carranza-Renteria, T. Fistel, S. Husain-Wilson (Boca Raton, USA)
Relating Movement Behaviour and Non-motor Characteristics in People with Parkinson’s Disease: a Compositional Data Analysis Approach

K. Larsson, H. Johansson, D. Peterson, J. Sedhed, B. Leavy (Stockholm, Sweden)
Relationship Between Alpha-Synuclein Aggregation Profiles, Imaging Biomarkers, and Disease Severity in a Phase 2 Study of ATH434 in MSA

M. Bradbury, P. Trujillo, K. Hett, C. Wong, C. Lucas, K. Kmiecik, D. Stamler, D. Claassen (Newark, USA)
Relationship Between Cortico-basal ganglia Beta Oscillations and Excessive Daytime Sleepiness in Parkinsonism

A. Verma, K. Acedillo, B. Nandakumar, N. Hjelle, H. Baker, D. Schneck, B. Mohanty, M. Fiecas, J. Wang, M. Howell, C. Mackinnon, J. Vitek, L. Johnson (Minneapolis, USA)
Relationship Between Improvement in “On” Time, Nonmotor Symptoms, and Quality of Life in Adults Treated With Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease

K. Chaudhuri, P. Odin, J. Aldred, L. Bergmann, J. Homola, R. Gupta, A. Antonini, M. Soileau (Spokane, USA)
Relationship Between Motor Subtypes and Central and Peripheral Neurodegeneration in Early Parkinson’s Disease: A Study Using DAT SPECT and SUDOSCAN

T. Shimizu, S. Moriyasu, K. Taneda, N. Tokuda, Y. Ugawa, R. Hanajima (Tokyo, Japan)
Relationships Between Preferred Walking Speed and Accelerations at the Head and Trunk in Individuals with Parkinson’s Disease (PD) and Healthy Elderly

P. Prupetkaew, A. Grunsfeld, S. Morrison, D. Russell (Norfolk, USA)
Reliability and Validity of In-home Tele-Neuropsychological Testing in Patients with Parkinson’s Disease: A Randomized Trial

S. Sperling, J. Dong, B. Lapin, Y. Li (Cleveland, USA)
Remission of Tardive Dyskinesia in Patients Receiving Long-Term Valbenazine Treatment

A. Cutler, L. Bahroo, K. Aldrich, E. Liu, C. Zeng, K. Farahmand (Syracuse, USA)
Remote Deep Brain Stimulation Programming for Parkinson’s Disease: A Multicenter Randomized Non-Inferiority Trial

J. Shaik, V. Zentsch, C. Buhmann, T. Kinfe, M. Regensburger, J. Rumpf, A. Schnitzler, G. Höglinger, J. Mehrkens, T. Koeglsperger (Muenster, Germany)
Repeated Scanning Ultrasound in an Alpha-synuclein Preformed Fibril model

V. Purrer, K. Roffey, G. Richter-Stretton, J. Song, G. Leinenga, L. Chen, E. Albornoz Balmaceda, J. Götz (St Lucia, Australia)
Repetitive Transcranial Magnetic Stimulation For Freezing Of Gait And Motor Function In Parkinson’s Disease: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)
Rescue GPi DBS for Severe Dyskinesias and Dystonia in Long-Term STN DBS Parkinson’s Patients: A Case Series

J. Brainer, P. Brainer, A. Brainer, S. Laurentino, R. Bandim, A. Oliveira, M. Cavalcanti, P. Brainer, C. Vidal (Recife, Brazil)
Rescuing alpha-synuclein toxicity through neuron-specific enhancement of autophagy

J. Chua, M. Farah, S. Tewari, A. Parvataneni, V. Dawson, T. Dawson (Baltimore, USA)
Resolution Dependence of Machine Learning for Differential Diagnosis of Parkinsonian Eye Movements

O. Bredemeyer, S. Patel, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)
Response Inhibition and Cortical Excitability in selected SCA subtypes in an Indian Cohort

S. Majumdar, S. Banerjee, S. Choudhury, S. Sarkar, A. Bayen, J. Ganguly, H. Kumar (Kolkata, India)
Response to Bilateral GPi DBS in a Patient with DYT30

N. Pulley, M. Luciano Palenzuela (San Francisco, USA)
Resting-state EEG analysis defines the signature of CACNA1A and GAA-FGF14 related channelopathies

E. Indelicato, R. Angerbauer, I. Unterberger, M. Amprosi, W. Nachbauer, S. Boesch, M. Cesari (Innsbruck, Austria)
Restoration of Ambulation in an Adolescent with Tardive Dystonia after Pallidal DBS

HB. Burks, T. Larsh, J. Skoch, DL. Gilbert, SW. Wu (Cincinnati, USA)
Results From a Dose-Blinded, Phase II Extension Study Evaluating Long-Term Efficacy, Safety and Tolerability of Minzasolmin in Participants With Parkinson’s Disease

C. Beuter, S. Carson, M. Key Prato, N. Massat, R. Maguire, A. Dhar Koul, E. Lucassen, J-M. Riethusien, I. Giunzioni, A. Pethe, G. Goethals, A. Khanna, Z. Ali (Monheim am Rhein, Germany)
Results from the PRIME-UK Randomised Controlled Trial

K. Lloyd, E. Tenison, C. Mcdonald, S. Haworth, C. Glover, R. Harrison, D. Pendry-Brazier, M. Smith, F. Lithander, A. Cullen, K. Naylor, N. Giles, T. Gabriel, P. Kamnerdsupaphon, A. Nodehi, Y. Ben-Shlomo, EJ. Henderson (Bristol, United Kingdom)
Retention & Safety in a Home-Based Fracture Prevention Trial of Zoledronate vs Placebo (TOPAZ) in Persons with Neurodegenerative Parkinsonism (NDP)

C. Tanner, N. Luthra, S. Goldman, R. Zuzuarregui, E. Brown, C. Meng, J. Perkins, L. Racelo, T. Hue, C. Schambach, D. Kriesel, H. Barnes, T. Stiep, I. Bledsoe, P. Ranola, M. Schwarzschild, R. Dorsey, A. Espay, S. Krischer, C. Comella, M. Siddiqui, F. Gao, M. Ledoux, E. Byrd, I. Litvan, N. Mcfarland, K. Mitchell, D. Standaert, J. Beck, K. Williams, M. Drake, D. Bauer, K. Lyles, S. Cummings, THE. Topaz Study-Team (San Francisco, USA)
Rethinking Parkinsonism: Limitations in Clinical Diagnosis

S. Lallani, K. Poston (Stanford, USA)
Retinal Structural Changes in Parkinson’s Disease: insight into GBA1-Related PD and non-mutated PD

G. Di Rauso, M. Giacomelli, G. Portaro, S. Grisanti, V. Fioravanti, L. Caprari, G. Toschi, G. Argenziano, R. Sabadini, L. Taruffi, A. Scaglioni, E. Monfrini, A. Di Fonzo, M. Vecchi, F. Cavallieri, F. Valzania (Reggio Emilia, Italy)
Retro walking: A Potential Indicator of Physical Frailty in Parkinson’s Disease.

M. van Emde-Boas, C. Stonsaovapak, N. Bohnen, C. Pongmala (Ann Arbor, USA)
Retrospective analysis of MSA diagnosis in a neuroscience hospital

M. Wazil, M. Farhan Abdulla, J. Mitchell, D. Damodaran (Liverpool, United Kingdom)
Retrospective Analysis of our Supportive Care Clinic and Lifestyle Improvement Fitness Program

N. Hellmers, A. Weiss, B. Katz, S. Fine, A. Aminpour, A. Yoo, H. Ooi, H. Sarva (New York, USA)
Retrospective Analysis of the Neuropsychological Profiles of Parkinson’s Disease Patients Selected for Deep Brain Stimulation Surgery in Hawaii.

E. Krening, A. Ford, M. Bruno, T. Umaki (Honolulu, USA)
Retrospective series of adult-onset myoclonus presenting to an outpatient movement disorders clinic

M. Hamed, K. Oh, D. Zarandi, M. Oluleye, A. Zaher, J. Elsaygh, S. Rizly, X. Ma, H. Ooi, H. Sarva, M. Salgado, D. Victor (Brooklyn, USA)
Returning Secondary Health Findings in the PD GENEration study

M. Dini, K. Ghosh Galvelis, N. Bothwick, L. Caboy, M. Caulfield, R. de Leon, A. Dilliott, I. Khaderi, S. Rao, A. Yake, A. Coral Zambrano, R. Bhisetti, S. Lawrence, S. Li, Y. Lu, U. Ragunathan, T. Foroud, V. Caceres, L. Cook, K. Fiallos, L. Heathers, R. Hodges, A. Miller, A. Neibaur, M. Rumbaugh, M. Totten, J. Verbrugge, A. Hall, K. Marder, I. Mata, N. Mencacci, M. Nance, T. Simuni, M. Schwarzschild, A. Wills, H. Gao, C. Blauwendraat, J. Beck, R. Alcalay (Miami, USA)
Revealing Novel Genetic Contributors to Parkinson’s Disease in a Chinese Cohort: An Elaborate Examination within the CPD10KGP

Z. Liu, Y. Zhao, H. Pan, B. Tang (Changsha, China)
Risk Factors and Outcome of Dopamine Dysregulation Syndrome in a large Chinese Parkinson’s Disease Cohort

Y. Xiao, S. Kang, R. Ou, W. Song, H. Shang (Chengdu, China)
Risk factors for central nervous system side effects of amantadine

M. Nagai, N. Miyaue, Y. Ito, Y. Yamanishi, R. Ando, Y. Ihara (Ehime, Japan)
Risk Factors for DBS Hardware Infections

K. Hu, K. Stefanescu, X. Lei, S. Cen, B. Lee, D. Lee, X. Mason (Los Angeles, USA)
Risk factors in a population with high prevalence of Parkinson’s disease in Chile

ME. Contreras Pinto, U. Hernandez Villarroel, N. Angel, F. Pancetti Vaccari, B. Soto, M. Ramirez, M. Vera Amoroso, J. Otero Olmos, G. Oneto Diaz, C. Morales (la serena, Chile)
Risk of Motor Complications in Early Parkinson’s Disease Patients Treated with Opicapone in the EPSILON study: Effect of Levodopa Dose

J. Ferreira, O. Rascol, F. Stocchi, A. Antonini, H. Brigas, J. Moreira, JF. Rocha, M. Fonseca, D. Ramos, J. Holenz, W. Poewe (Lisbon, Portugal)
Robust Computation of Subcortical Functional Connectivity Guided by Quantitative Susceptibility Mapping: An Application in Parkinson’s Disease Diagnosis

J. Qin, C. He, Y. Ma, X. Guan, M. Zhang (Hangzhou, China)
Role and Integration of a Dietitian into the Deep Brain Stimulation Multidisciplinary Screening Process

T. Mehta, P. Graese, A. Barnes, E. Truscott, C. Hess, M. Okun (Gainesville, USA)
Role of 7-Tesla MRI in assessing clinical symptoms in CSF1R-Related Disorders

T. Chmiela, J. Dulski, A. Strongosky, E. Middlebrooks, Z. Wszolek (Katowice, Poland)
Role of APOE Polymorphism and CSF Markers of AD Co-Pathology in the Cognitive Trajectories of Sporadic and Genetic Parkinson’s Disease: A Longitudinal Cohort Study

R. Botta, J. Locascio, R. Ye, A. Goodheart, S. Gomperts (Boston, USA)
Role of presenilin 1 variants in parkinsonism

M. Kinoshita, H. Ohara, R. Sasaki, K. Tamura, A. Elangovan, HW. Suresh Babu, S. Muthukumar, M. Iyer, B. Vellingiri (Kyoto, Japan)
Role of the other babinski sign in hemifacial spasm

YC. Chen, SL. Chen (Taichung, Taiwan)
Role of the subthalamic nucleus in working memory in patients with deep brain stimulation for Parkinson’s disease (protocol)

S. Poveda, J. Abril Ronderos, M. Lamprea Rodriguez, O. Bernal-Pacheco (Bogota, Colombia)
Role of the UPSIT score in performing synucleinopathy diagnosis

D. Rebolledo Garcia, JC. Lopez Hernandez, JA. Romero Mera (New York, USA)